Issue Date |
Title |
Author(s) |
10-Oct-2020 |
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study |
Chang, Ying-Jun;Wu, De-Pei;Lai, Yong-Rong;Liu, Qi-Fa;Sun, Yu-Qian;Hu, Jiong;Hu, Yu;Zhou, Jian-Feng;Li, Juan;Wang, Shun-Qing;Li, Wei;Du, Xin;Lin, Dong-Jun;Ren, Han-Yun;Chen, Fang-Pin;Li, Yu-Hua;Zhang, Xi;Huang, He;Song, Yong-Ping;Jiang, Ming;Hu, Jian-Da;Liang, Ying-Min;Wang, Jing-Bo;Xiao, Yang;Huang, Xiao-Jun |
2016 |
Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China |
Lu, Jin;Hou, Jian;Liu, Kai-Yan;Parmar, Simrit;De La Fuente, Adolfo;Andersson, Borje;Yan, ChenHua;Zhou, Daobin;Tan, Daryl;Ritchie, David;Wu, Deipei;Shpall, Elizabeth;Laport, Ginna G.;Li, JianYong;Hu, Jiong;Zhang, Lian Sheng;Wang, Michael;Malhotra, Pankaj;Jiang, Qian;Qin, Yazhen;Wong, Raymond;Champlin, Richard;Issaragrisil, Surapol;Iyer, Swaminathan;Mathews, Vikram;Wang, Yu;Hu, Yu;Xiao, Zhijian;Shao, Zonghong;Rosengarten, Rafael;Steuernagle, Jon;Xiao, Jun Huang;Orlowski, Robert;Chim, Chor Sang |
Feb-2022 |
Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis |
Mo, Xiao-Dong;Hong, Shen-Da;Zhao, Yan-Li;Jiang, Er-Lie;Chen, Jing;Xu, Yang;Sun, Zi-Min;Zhang, Wei-Jie;Liu, Qi-Fa;Liu, Dai-Hong;Wan, Ding-Ming;Mo, Wen-Jian;Ren, Han-Yun;Yang, Ting;Huang, He;Zhang, Xi;Wang, Xiao-Ning;Song, Xian-Min;Gao, Su-Jun;Wang, Xin;Chen, Yi;Xu, Bing;Jiang, Ming;Huang, Xiao-Bing;Li, Xin;Zhang, Hong-Yu;Wang, Hong-Tao;Wang, Zhao;Niu, Ting;Wang, Ji-Shi;Xia, Ling-Hui;Liu, Xiao-Dan;Li, Fei;Zhou, Fang;Lang, Tao;Hu, Jiong;Wu, Sui-Jing;Huang, Xiao-Jun |
Jun-2020 |
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study |
Qian, Jie-Jing;Hu, Xiaoxia;Wang, Ying;Zhang, Yi;Du, Juan;Yang, Min;Tong, Hongyan;Qian, Wen-Bin;Wei, Juying;Yu, Wenjun;Lou, Yin-Jun;Mao, Liping;Meng, Hai Tao;You, Liang-Shun;Wang, Libing;Li, Xia;Huang, Xin;Cao, Li-Hong;Zhao, Jian-Zhi;Yan, Xiao Yan;Chen, Yu-Bao;Chen, Yu;Zhang, Su-Jiang;Jin, Jie;Hu, Jiong;Zhu, Hong-Hu |
2017 |
Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in a Clinical Practice Setting in China |
Zhang, Xiaohui;Hu, Jiong;Hu, Yu;Huang, He;Jin, Jie;Li, Juan;Liu, Qifa;Shao, Zonghong;Wang, Jianxiang;Wang, Quanshun;Wu, Depei;Huang, Xiaojun |
2019 |
Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study |
Wang, Ling;Wang, Ying;Hu, Jiong;Sun, Yuqian;Huang, He;Chen, Jing;Li, Jianyong;Ma, Jun;Li, Juan;Liang, Yingmin;Wang, Jianmin;Li, Yan;Yu, Kang;Hu, Jianda;Jin, Jie;Wang, Chun;Wu, Depei;Xiao, Yang;Huang, Xiaojun |
Apr-2021 |
Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study |
Sun, Yuqian;Hu, Jiong;Huang, He;Chen, Jing;Li, Jianyong;Ma, Jun;Li, Juan;Liang, Yingmin;Wang, Jianmin;Li, Yan;Yu, Kang;Hu, Jianda;Jin, Jie;Wang, Chun;Wu, Depei;Xiao, Yang;Huang, Xiaojun |
2016 |
Does High-Dose Cytarabine Cause More Fungal Infection in Patients With Acute Myeloid Leukemia Undergoing Consolidation Therapy A Multicenter, Prospective, Observational Study in China |
Wang, Ling;Hu, Jiong;Sun, Yuqian;Huang, He;Chen, Jing;Li, Jianyong;Ma, Jun;Li, Juan;Liang, Yingmin;Wang, Jianmin;Li, Yan;Yu, Kang;Hu, Jianda;Jin, Jie;Wang, Chun;Wu, Depei;Xiao, Yang;Huang, Xiaojun |
2018 |
Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China |
Zhang, Xiaohui;Hu, Jiong;Hu, Yu;Huang, He;Jin, Jie;Li, Juan;Liu, Qifa;Shao, Zonghong;Wang, Jianxiang;Wang, Quanshun;Wu, Depei;Huang, Xiaojun |
Nov-2020 |
Fluconazole is as effective as other anti-mold agents in preventing early invasive fungal disease after allogeneic stem cell transplantation: assessment of antifungal therapy in haematological disease in China |
Sun, Yuqian;Hu, Jiong;Huang, He;Chen, Jing;Li, Jianyong;Ma, Jun;Li, Juan;Liang, Yingmin;Wang, Jianmin;Li, Yan;Yu, Kang;Hu, Jianda;Jin, Jie;Wang, Chun;Wu, Depei;Xiao, Yang;Huang, Xiaojun |
2017 |
Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China |
Huang, Xiao Jun;Liu, Kaiyan;Ritchie, David;Andersson, Borje;Lu, Jin;Hou, Jian;Burguera, Adolfo de la Fuente;Wang, JianXiang;Yeoh, Allen;Yan, Chenhua;Zhou, Daobin;Tan, Daryl;Kim, Dong Wook;Wu, Depei;Shpall, Elizabeth;Kornblau, Stephen;Neelapu, Sattava;Hongeng, Suradej;Li, Jianyong;Hu, Jiong;Zhang, Lian Sheng;Wang, Michael;Malhotra, Pankaj;Jiang, Qian;Qin, Yazhen;Wong, Raymond;Champlin, Richard;Hagemeister, Frederick;Westin, Jason;Iyer, Swaminathan;Mathews, Vikram;Wang, Yu;Hu, Yu;Xiao, Zhijian;Shao, Zonghong |
2012 |
Homoharringtonine-Based Induction Regimens for Patients with De Novo Acute Myeloid Leukemia: A Multicenter Randomized Controlled Phase 3 Trial |
Jin, Jie;Wang, Jianxiang;Chen, Feifei;Wu, Depei;Hu, Jiong;Zhou, Jianfeng;Hu, Jianda;Wang, Jianmin;Li, Jianyong;Huang, Maojun;Ma, Jun;Ji, Chunyan;Xu, Maoping;Yu, Kang;Ren, Hanyun;Zhou, Yuhong;Tong, Yin;Mi, Yingchang;Du, Xin;Chen, Baoan;Chen, Zhu;Chen, Sai-Juan |
2013 |
Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial |
Jin, Jie;Wang, Jian-Xiang;Chen, Fei-Fei;Wu, De-Pei;Hu, Jiong;Zhou, Jian-Feng;Hu, Jian-Da;Wang, Jian-Min;Li, Jian-Yong;Huang, Xiao-Jun;Ma, Jun;Ji, Chun-Yan;Xu, Xiao-Ping;Yu, Kang;Ren, Han-Yun;Zhou, Yu-Hong;Tong, Yin;Lou, Yin-Jun;Ni, Wan-Mao;Tong, Hong-Yan;Wang, Hua-Feng;Mi, Ying-Chang;Du, Xin;Chen, Bao-An;Shen, Yi;Chen, Zhu;Chen, Sai-Juan |
2015 |
Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide |
Shen, Yang;Fu, Ya-Kai;Zhu, Yong-Mei;Lou, Yin-Jun;Gu, Zhao-Hui;Shi, Jing-Yi;Chen, Bing;Chen, Chao;Zhu, Hong-Hu;Hu, Jiong;Zhao, Wei-Li;Mi, Jian-Qing;Chen, Li;Zhu, Hong-Ming;Shen, Zhi-Xiang;Jin, Jie;Wang, Zhen-Yi;Li, Jun-Min;Chen, Zhu;Chen, Sai-Juan |
7-Jun-2021 |
A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma |
Cui, Jiujie;Yang, Haiyan;Liu, Jue;Chen, Donghui;Hu, Jiong;Zhang, Haiyan;Wang, Yu;Han, Ting;Mao, Tiebo;Jiao, Feng;Biskup, Ewelina;Pan, Yaotian;Liu, Min;Wang, Liwei |
15-Nov-2022 |
A Phase IV, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) As a Myeloablative Conditioning Regimen in Chinese Multiple Myeloma Patients Undergoing Autologous Stem Cell |
Wang, Fengrong;Cai, Zhen;Zou, Dehui;Chen, Wenming;Song, Yongping;Fu, Chengcheng;Hu, Jiong;Yang, Ting;Chen, Xinchuan;Yan, Jinsong;Liu, Kaiyan |
20-May-2020 |
PhaseI/IIa Study evaluating the safety, efficacy of K-001 in advanced pancreatic ductal adenocarcinoma. |
Cui, Jiujie;Yang, Haiyan;Chen, Donghui;Hu, Jiong;Zhang, Haiyan;Jiao, Feng;Liu, Min;Liu, Jue;Wang, Li-Wei |
2018 |
Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study |
Zhu, Jun;Huang, Huiqiang;Chen, Huan;Zhang, Xi;Li, Zengjun;Wu, Depei;Zhou, Daobin;Song, Yongping;Hu, Yu;Liang, Yingmin;Ren, Hanyun;Huang, He;Li, Nainong;Chen, Hu;Hu, Jiong;Li, Jianyong;Meng, Robin;Wu, Junlong;Yu, Dong;Huang, Xiaojun |
2018 |
PML Mutation in PML-Rar alpha Alters PML Nuclear Body Organization and Induces ATRA Resistance in Acute Promyelocytic Leukemia |
Zhu, Hong-Hu;Wu, Congying;Sun, Yujie;Hu, Jiong |